NCT05317819 2025-12-18Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular CarcinomaPolaris GroupPhase 3 Recruiting300 enrolled
NCT06034977 2023-09-13Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular CarcinomaChang Gung Memorial HospitalPhase 2 Recruiting120 enrolled